8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

Date of Report (Date of earliest event reported): September 10, 2008

LANNETT COMPANY, INC.

(Exact Name of Registrant as Specified in Its Charter)

Commission File No. 001-31298

State of Delaware	23-0787699
(State of Incorporation)	(I.R.S. Employer I.D. No.)

9000 State Road

Philadelphia, PA 19136

(215) 333-9000

(Address of principal executive offices and telephone number)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 8.01 Other Events.

On September 10, 2008, Lannett Company, Inc. announced that its chairman, William Farber, has taken a temporary medical leave of absence for health reasons.  Jeffrey Farber, a non-employee director of Lannett and William Farber’s son, has been appointed to serve as interim chairman of the board.

Item 9.01 Financial Statements and Exhibits.

(d)	Exhibits
99.1	September 10, 2008 Press Release

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

	LANNETT COMPANY, INC.
Date: September 12, 2008	By:	/s/ Brian Kearns
	Vice President of Finance, Treasurer, Secretary and Chief Financial Officer

2

EX-99.1

Exhibit 99.1

Contacts:	Robert Jaffe/Evan Pondel
	PondelWilkinson Inc.
	(310) 279-5980

LANNETT COMPANY ANNOUNCES WILLIAM FARBER, CHAIRMAN OF THE BOARD, TAKES MEDICAL LEAVE

— Company Appoints Jeffrey Farber as Interim Chairman

Philadelphia, PA, September 10, 2008:  Lannett Company Inc. (AMEX: LCI) today announced that William Farber, the company’s chairman since 1991, has taken a temporary leave of absence for health reasons.  The company also said that Jeffrey Farber, a non-employee director of Lannett and William Farber’s son, has been appointed to serve as interim chairman of the board.

Jeffrey Farber has spent more than 25 years in the generic industry in various capacities.  He has worked with the senior management of Lannett and continues to support their efforts to distinguish Lannett from its generic competitors, including the company’s efforts to vertically integrate in the area of pain management.

“I look forward to my father’s speedy recovery and return as chairman”, said Jeffrey Farber.  “During his absence, I intend to pursue the policies and direction he has supported.”

Lannett Company:

Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of indications.  For more information, visit Lannett Company’s website at www.lannett.com.